RecruitingNCT03720197

Registry of Patients Living With Type 1 Diabetes

Registry of Individuals With Type 1 Diabetes Living in Canada: The BETTER Registry


Sponsor

Institut de Recherches Cliniques de Montreal

Enrollment

6,000 participants

Start Date

Feb 20, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

A registry of individuals with type 1 diabetes open to all patients with type 1 diabetes living in Canada will be established. The objective of this registry will be to measure the frequency and the severity of episodes of hypoglycemia. Participants will be invited to answer questionnaires about the frequency of their hypoglycemic episodes, their fear about hypoglycemia, their symptoms of hypoglycemia, the factors in cause (insulin therapy, nutrition, exercise, etc.), etc. Participation to the registry is divided in 3 phases. The first phase is mandatory for all participants. Phases 2 and 3 are optional.


Eligibility

Inclusion Criteria2

  • Diagnosis of type 1 diabetes
  • Living in Canada

Exclusion Criteria2

  • Type 2 diabetes
  • Gestational diabetes

Interventions

OTHEROnline questionnaire - Phase 1

Draw an overall picture of the population with type 1 diabetes in Canada in terms of demographics, diabetes treatment, hypoglycemia frequency and diabetes complications.

OTHEROnline questionnaire - Phase 2

Characterize the causes, experience and consequences of hypoglycemia.

OTHEROnline questionnaire - Phase 3

Collect information on diabetes and hypoglycemia treatment, hyperglycemia management, sleep habits, depression, physical activity and the benefits of technologies to reduce the frequency of hypoglycemia.

OTHERFood questionnaire

24-hour food recall questionnaire

OTHERPedometer

Participants will wear a podometer for 14 consecutives days

OTHERWaist circumference

Participants will be asked to measure their waist circumference

OTHERBlood and urine tests

Participants will be invited to send us their latests blood and urine test results.

OTHERList of medications

Participants will be invited to send us their list of medications

OTHERContinuous glucose monitor

Participants will be invited to send us the latest report of their continuous glucose monitor


Locations(7)

Alberta Diabetes Institute

Edmonton, Alberta, Canada

Institut de recherches cliniques de Montréal

Montreal, Quebec, Canada

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, Canada

Centre Hospitalier Universitaire Sainte-Justine

Montreal, Quebec, Canada

McGill University Health Centre

Montreal, Quebec, Canada

Centre Hospitalier Universitaire de Québec-Université Laval

Québec, Quebec, Canada

Centre hospitalier universitaire de Sherbrooke

Sherbrooke, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03720197


Related Trials